Why the study?
Femoral cannulation during minimally invasive heart valve surgery is suspected to increase stroke risk through retrograde flow, but evidence comparing it to antegrade axillary cannulation is scarce.
Does axillary cannulation reduce the risk of manifest stroke within 7 days postoperatively compared to femoral cannulation in patients undergoing minimally invasive heart valve surgery?
Population
848 target patients aged ≥ 18 years scheduled for minimally invasive heart valve surgery
Comparison
Axillary cannulation vs femoral cannulation
Design
Multicenter prospective randomized controlled trial protocol
Follow-up
7 days postoperatively
Authors
Loading...
The FAMI RCT will determine whether axillary cannulation reduces stroke versus femoral in MIS valve surgery; leaves open current practice.
Does axillary cannulation reduce the risk of manifest stroke within 7 days postoperatively compared to femoral cannulation in patients undergoing minimally invasive heart valve surgery?
This protocol outlines a multicenter randomized trial to determine if axillary cannulation is superior to femoral cannulation for reducing stroke risk during minimally invasive heart valve surgery.
Kruse et al. (2023) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: